ANKRD34A Activators constitute a class of chemical compounds recognized for their ability to modulate the activity of the ANKRD34A gene. ANKRD34A, also known as Ankyrin Repeat Domain 34A, is a gene that encodes a protein whose functions are still being explored within the field of molecular biology. Activators of ANKRD34A are molecules that possess the capacity to either enhance the expression of the ANKRD34A gene or augment its biological activity within a cell. These compounds serve as important tools for researchers interested in unraveling the biological significance of ANKRD34A and its potential involvement in various cellular functions.
The specific mechanisms by which ANKRD34A activators exert their effects are currently a subject of active scientific investigation. These molecules may act at the transcriptional or post-transcriptional level, potentially influencing the production of ANKRD34A protein or modifying its interactions with other cellular components. By manipulating ANKRD34A activity, researchers aim to decipher its biological roles, which may encompass participation in cellular signaling pathways, molecular pathways, or cellular responses to internal or external cues. Investigating ANKRD34A activators offers the potential to shed light on the molecular pathways and cellular processes governed by this gene, thereby advancing our understanding of its significance in normal cellular physiology and potentially leading to novel insights in fields such as molecular biology and genetics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can interact with nuclear receptors and potentially influence gene expression patterns. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can lead to changes in transcription factor activity and gene expression. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, might impact gene expression through its role as an HDAC inhibitor. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, potentially inhibiting Sp1 transcription factor binding and altering gene expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which may lead to modulation of gene expression through the MAPK/ERK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can affect gene expression by altering AKT signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, PD98059 can affect gene transcription by modulating the MAPK/ERK signaling pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can regulate gene expression by acting through glucocorticoid receptors as a transcription factor. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK which can lead to changes in gene expression associated with energy metabolism. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO can induce changes in gene expression, possibly due to its role as a solvent that affects cellular membranes. | ||||||